Substrate Specificity of Hybrid Modules from Peptide Synthetases*

(Received for publication, October 2, 1996, and in revised form, December 4, 1996)

Andrea Elsner Dagger , Heinrich Engert Dagger , Wolfram Saenger Dagger , Leendert Hamoen §, Gerard Venema § and Frank Bernhard Dagger

From the Dagger  Freie Universität Berlin, Institut für Kristallographie, Takustrasse 6, D-14195 Berlin, Germany and the § Department of Genetics, University of Groningen, Kerklaan 30, NL-9751 NN Haren, The Netherlands

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

Homologous modules from two different peptide synthetases were analyzed for functionally equivalent regions. Hybrids between the coding regions of the phenylalanine-activating module of tyrocidine synthetase and the valine-activating module of surfactin synthetase were constructed by combining the two reading frames at various highly conserved consensus sequences. The resulting DNA fragments were expressed in Escherichia coli as C-terminal fusions to the gene encoding for the maltose-binding protein. The fusion proteins were purified, and the amino acid specificities, the acceptance of different nucleotide analogues, and the substrate binding affinities were analyzed. We found evidence for a large N-terminal domain and a short C-terminal domain of about 19 kDa within the two modules, which are separated by the sequence motif GELCIGG. The two domains could be reciprocally transferred between the two modules, and the constructed hybrid proteins showed amino acid adenylating activity. Hybrid proteins fused at various consensus motifs within the two domains were inactive, indicating that the domains may fold independently and represent complex functional units. The N-terminal domain was found to be responsible for the amino acid specificity of the modules, and it is also involved in the recognition of the ribosyl and the phosphate moieties of the nucleotide substrate. For tyrocidine synthetase I, we could confine the sites for amino acid specificity to a region of 330 residues. The C-terminal domain is essential for the enzymatic activity and has a strong impact on the specific activity of the modules.


INTRODUCTION

Tyrocidine synthetase and surfactin synthetase are multifunctional peptide synthetases produced by Bacillus brevis and Bacillus subtilis, respectively (1-5). The enzymes belong to a superfamily of adenylate-forming enzymes (6-8). Small peptides like tyrocidine A and surfactin are formed by a non-ribosomal pathway according to the thio-template mechanism (6, 9). Prior to incorporation, amino acids and related compounds are activated as adenylates by cleavage of ATP and release of pyrophosphate. Peptide synthetases exhibit a modular structure with several linked modules of about 100 kDa (1, 10-16). Each module is responsible for recognition, activation, and incorporation of a specific amino acid constituent into the peptide product. Various modules of peptide synthetases have been sequenced, and several highly conserved motifs were found (7, 8, 11, 14, 17-19). Mutagenesis and cross-linking experiments gave evidence for the involvement of most of these motifs in the binding of ATP and the adenylate forming activity (20-23). A serine residue in the highly conserved sequence motif LGG(H/D)S at the C terminus of the modules was clearly identified as the site for covalent attachment of a phosphopantetheine cofactor (24-26). The deletion of the cofactor attachment site in the phenylalanine-activating modules of tyrocidine synthetase I and gramicidin S synthetase I did not affect the amino acid adenylate forming activity (27, 28). The regions responsible for the amino acid substrate specificity have not been analyzed so far, and they are supposed to be located within the variable regions of amino acid adenylating modules.

The modular structure of peptide synthetases implicates genetic approaches to generate optimized peptide antibiotics. Altered peptides have been produced by recombinant peptide synthetases after the exchange of large regions containing complete amino acid adenylating modules (29). However, nothing is known about the structure or conformation of peptide synthetases and about interactions between specific modules. The closer confinement of active sites and the identification of residues involved in the substrate specificity could be a prerequisite for the construction of recombinant peptide synthetases with no or only little interference with the functional conformation of the altered protein.

We report a genetic approach to further confine the putative substrate binding pockets within peptide synthetase modules. We have chosen tyrocidine synthetase I with specificity for phenylalanine (2, 4) and the valine-activating module of surfactin synthetase as models (15, 30). Both modules are well characterized and can be overexpressed and isolated as active proteins from the heterologous host Escherichia coli (2, 24, 27). Variable regions of the two modules with different substrate specificities were combined reciprocally by genetic recombination. The fusion sites were located within the conserved motifs and were created by introduction of unique restriction sites after silent mutations. With this strategy, the sequence and the distance of the conserved motifs to each other remain unaltered, and variable regions are transferred as complete units to the constructed hybrids. Putative substrate binding pockets located within the variable regions could be transferred to the hybrid protein. We could confine the substrate recognition sites to the N-terminal part of the modules and give first evidence for the presence of two independently transferrable domains in amino acid adenylating units of peptide synthetases.


EXPERIMENTAL PROCEDURES

Strains, Plasmids, and Media

The E. coli strain XL1-Blue (31) was used as host for plasmids and for isolation of proteins. Cells were routinely grown in Luria broth at 37 °C. For the isolation of proteins, 500 ml of LB were inoculated 1:100 from a fresh overnight culture, induced with 0.5 mM isopropyl-1-thio-beta -D-galactopyranoside at an A590 of 0.5 and harvested after another 3 h of incubation. The cell pellet was immediately used for enzyme purification or stored at -40 °C. For the expression of proteins, the corresponding DNA fragments were cloned into the expression vectors pMalc2 (New England Biolabs) or pQE30 (Qiagen).

DNA Manipulations and PCR1

DNA techniques like restriction, ligation, DNA isolation, and transformations were performed as described (32). For PCR we routinely used Vent DNA polymerase (New England Biolabs) with a denaturation step at 94 °C for 30 s, an annealing step at 42 °C for 1 min, and a polymerization step at 72 °C for 1 min. 20 cycles were performed with a final polymerization step of 5 min at 72 °C. PCR products were purified with the Jet pure kit (Genomed).

Synthetic Oligonucleotides

Oligonucleotides were purchased from TIB MOLBIOL. The following primers were used for construction of the truncated or hybrid modules (f, forward primer; r, reverse primer; T, template plasmid pGC12 (2); S, template plasmid pMALD (30)): His-Srf-2, 1Sf (GCG GAT CCA TGA GCA AAA AAT CGA TTC AAA AGG) and 1Sr (GCG GTA CCT TAC GCT AAT TTC TTT TCA CTC TCT G); Srf-2, 2Sf (CCG AAT TCA TGA GCA AAA AAT CGA TTC AAA AG) and 2Sr (GCT CTA GAC CTA CGC TAA TTT CTT TTC AC); Srf-3, 3Sf (GCG GAT CCG TGT TTG AAG AGC AAG C) and 3Sr (= 2Sr); ST-V, 4Sf (= 2Sf), 4Sr (CGG AGC TCA CCA GGC GCG CCG ATT GG), 4Tf (GCG AGC TCT GCA TCG GCG GAG TCG GCT TGG), and 4Tr (GCT CTA GAC TAA ATC GAT TCT GTC TCG GTT C); ST-II, 5Sf (= 2Sf), 5Sr (GCC TTA AGA ACA GCC AGC ATG CCG ACA ACG), 5Tf (GCC TTA AGG CAG GCG GAG CCT ATG TGC), and 5Tr (= 4Tr); Tys-1, 6Tf (GGG GAT CCA TGT TAG CAA ATC AGG CCA ATC) and 6Tr (= 4Tr); Tys-2, 7Tf (CGG AAT TCT TCG AGG AAC AAG CAG) and 7Tr (= 4Tr); TS-VI, 8Tf (= 7Tf), 8Tr (GCC CCG GGA AGC TTC TGG GCG GCG TA), 8Sf (CGC CCG GGT ATA TGG TCC CTG CCC AC), and 8Sr (= 2Sr); TS-V.1, 9Tf (= 6Tf), 9Tr (CGG AGC TCG CCT TCG CTG CCA GTC GG), 9Sf (GCG AGC TCT GCG TAG GCG GAA TCG GTG), 9Sr (= 2Sr); TS-V.2, 10Tf (= 7Tf), 10Tr (= 9Tr), 10Sf (= 9Sf), and 10Sr (= 2Sr); TS-IV, 11Tf (= 7Tf), 11Tr (GCC ATA TGC ATT TAT GTA CCT GAG TTT GTC), 11Sr (CGC ATA TGG CCC GAC AGA AAA CAC G), and 11Sr (= 2Sr); TS-III, 12Tf (= 7Tf), 12Tr (CGA CCG GTC GTG CCT GAG GTG TAA ATG AC), 12Sf (CGA CCG GTA AAC CGA AAG GCG TCA TG), and 12Sr (= 2Sr).

Overexpression and Purification of Proteins

Frozen cells were suspended in 20 mM MES/HEPES buffer, pH 6.5, at a ratio of 1:5. The cells were disrupted by sonification for 15 min or by passing three times through a French pressure cell. The cell debris was pelleted by ultracentrifugation for 1 h at 90,000 × g. The crude extract was supplemented with NaCl at a final concentration of 200 mM and applied to a self-packed dextrin column for affinity chromatography. Prior to packing, dextrin from potato starch (Fluka) was washed and centrifuged several times until the supernatant remained clear. The dextrin was finally equilibrated in column buffer (20 mM MES/HEPES, pH 6.5, 200 mM NaCl). The affinity chromatography was carried out at 4 °C at a flow rate of 1 ml/min. After loading the crude extract, the dextrin column was washed extensively with column buffer, and bound protein was finally eluted with column buffer supplemented with 10 mM maltose. For some constructs, the protein fractions with amino acid adenylate forming activity were pooled, dialyzed against 20 mM Tris/Tris-Bis propane, pH 7.0, and further purified with anion exchange chromatography on a self-packed column filled with POROS 10 HQ resin (PerSeptive Biosystems). Chromatography was done with the BioCADTM workstation (PerSeptive Biosystems) at a flow rate of 10 ml/min. Optimizations of specific chromatography steps were performed using the BioCADTM software (version 1.24.3). The final conditions for protein elution were as follows: Srf-2, 240 mM NaCl at pH 8.0; Tys-1, 380 mM at pH 7.0; TS-V.1, 160 mM NaCl at pH 7.0. The purification after anion exchange chromatography was 2.8-fold for proteins Srf-2 and Tys-1 and 5-fold for TS-V.1.

The fusion protein His-Srf-2 was purified by loading the crude extract on a self-packed column filled with POROS 20 MC resin (PerSeptive Biosystems) with chelated nickel ions. Bound proteins were eluted with 400 mM imidazole and subsequently loaded on a self-packed column filled with heparin (POROS HE, PerSeptive Biosystems). The His-Srf-2 protein eluted from the heparin with an NaCl gradient at 180 mM. A purification of 3.1-fold was achieved with the heparin column in relation to the eluate from the nickel column. All steps were done at a flow rate of 10 ml/min with the BioCADTM workstation.

Protein Determination and Electrophoretic Techniques

Protein concentration was routinely determined using the Bradford reagent (33) with bovine serum albumin as a standard. SDS-PAGE was performed in 10% polyacrylamide gels according to the method of Laemmli (34).

Activity Assay

Enzymes were tested by the ATP/PPi exchange reaction essentially as described previously (35). In the standard reaction, compounds were added at the following final concentrations: amino acid, 2 mM; Mg2+, 2.5 mM; ATP, 0.5 mM; PPi, 0.1 mM; MES/HEPES buffer, 10 mM, pH 6.5. 32P-Labeled PPi was added at a total count rate of 0.5 µCi. Unless otherwise stated, the enzymes were incubated for 15 min at 31 °C.


RESULTS

Expression of Terminal Deleted Modules from Tyrocidine Synthetase and Surfactin Synthetase in E. coli and Characterization of the Purified Proteins

The coding regions for tyrocidine synthetase I and the first module of surfactin synthetase II were truncated by terminal deletions to confine the minimal sizes responsible for amino acid adenylate forming activity. Several deletions were constructed by PCR or digestion with restriction enzymes (Fig. 1) and expressed as fusions with the maltose-binding protein in E. coli. The fusions were purified in two steps by affinity chromatography and anion exchange chromatography (Fig. 2), and activities were determined by the ATP/PPi exchange reaction.


Fig. 1. Constructed deletions and hybrids from the valine-activating module of surfactin synthetase II and the phenylalanine-activating tyrocidine synthetase I. Regions derived from surfactin synthetase are shown in white; regions derived from tyrocidine A synthetase are hatched. Conserved sequence motifs relevant to our work are shown as boxes and are numbered from I to VII. Black boxes represent motifs of the surfactin synthetase module; white boxes represent the motifs of the tyrocidine synthetase module. Motifs that are used as fusion sites are shown by striped boxes. The consensus sequences are as follows: I, HHIIXDGW; II, LKAGXAYVPID; III, YTSGTTGXPKG; IV, NXYGPTE; V, GELCIGG; VI, LPXYMVP; VII, LGGH/DSL (where X represents variable positions). The numbers of amino acid residues are given in parentheses after the designations of the modules. For hybrid modules, the numbers of residues derived from the two different modules are shown separately divided by a slash. Constructed modules with amino acid adenylating activity are in bold.
[View Larger Version of this Image (32K GIF file)]



Fig. 2. Expression and purification of truncated and hybrid peptide synthetase modules in E. coli. Proteins were separated on a 10% PAGE. Lane 1, Tys-1, crude extract; lane 2, Tys-1 after affinity chromatography; lane 3, Tys-1 after anion exchange chromatography; lane 4, Tys-2 after anion exchange chromatography; lane 5, TS-V.1 after anion exchange chromatography; lane M, molecular size standards (from top to bottom: 200, 116, 97, 66, and 45 kDa); lane 6, Srf-2, crude extract; lane 7, Srf-2 after affinity chromatography; lane 8, Srf-2 after anion exchange chromatography; lane 9, ST-V after affinity chromatography; lane 10, His-Srf-2 after anion exchange chromatography; lane 11, His-Srf-2, crude extract.
[View Larger Version of this Image (99K GIF file)]


The phenylalanine-activating domain of tyrocidine synthetase A was previously confined at the C-terminal end to amino acid position 535 relative to the wild type tyrocidine synthetase I (27). Further removal of 53 amino acids including the core motif VI from the C-terminal end results in an inactive protein (Fig. 1). In construct Tys-2, we deleted 31 amino acids from the N-terminal end of construct Tys-1 (Fig. 1). We could not detect any differences in substrate specificity between the two proteins. However, the specific activity of Tys-2 was reduced to about 11% when compared to Tys-1 (Table II). This gave evidence that the N-terminal end of the module Tys-1 contributes to an efficient conformation of the protein. With the construct Tys-2, the site of substrate specificity of tyrocidine synthetase I could be confined to a peptide with 504 amino acid residues.

Table II.

Amino acid specificity of truncated and hybrid modules

Specificity was determined in standard assay conditions with 2 mM amino acid. Values were averaged from at least 10 determinations.
Module Fusion sitea Phe Val/Ile Ile::Valb Specific activityc

% cpm/µg
Srf-1 None  - + 14 ± 7 1.80 ± 0.18 ×  105
Srf-2 None  - + 12 ± 6 1.61 ± 0.11 × 105
Srf-3 None  -  -  - Inactive
ST-II Motif II  -  -  - Inactive
ST-V Motif V  - + 18 ± 6 8.00 ± 0.72 × 102
Tys-1 None +  -  - 1.21 ± 0.06 × 105
Tys-2 None +  -  - 1.30 ± 0.10 × 104
Tys-3 None  -  -  - Inactive
TS-III Motif III  -  -  - Inactive
TS-IV Motif IV  -  -  - Inactive
TS-V.1 Motif V +  -  - 4.94 ± 0.49 × 105
TS-V.2 Motif V +  -  - 2.20 ± 0.18 × 103
TS-VI Motif VI  -  -  - Inactive

a  Core regions used for constructing hybrid genes.
b  Ratio of isoleucine to valine in percent.
c  Determined with valine or phenylalanine.

The valine-activating module of surfactin synthetase II was reduced in the construct Srf-2 to an active protein with 975 amino acid residues (Fig. 1). The C-terminal end of the protein Srf-2 corresponds exactly to the C-terminal end of the proteins Tys-1 and Tys-2. A N-terminal deletion of protein Srf-2 was constructed, which corresponds to the N terminus of protein Tys-2. The resulting protein Srf-3 contains 506 amino acid residues (Fig. 1) and was completely inactive when valine was provided as a substrate. Therefore, in contrast to Tys-2, residues further located to the N terminus may be essential for the amino acid adenylate formation of the first module of surfactin synthetase II.

Enzymatic Characterization of the Heterologously Expressed Module Srf-2

The protein Srf-2 was expressed as N-terminal fusion to the 42 kDa E. coli maltose-binding protein. To determine whether this N-terminal extension has any effects on the activity of the C-terminal amino acid adenylate-forming module, we expressed the protein Srf-2 also with a short N-terminal fusion of 12 amino acids, including a (His)6 tag. The expressed protein was designated His-Srf-2. The proteins Srf-2 and His-Srf-2 were purified and compared with regard to their activities. The two proteins accepted the amino acids valine and isoleucine at a ratio of about 10:1.4 in the amino acid adenylate-forming reaction. Differences in the specific activities were not detected. Both proteins had highest enzymatic activities at pH 6.5 at 31 °C. When different buffers were compared in the ATP/PPi exchange reaction under optimal conditions, we found the highest activities in a 20 mM MES/HEPES-buffered system.

Construction and Amino Acid Specificity of Hybrids from the Phenylalanine-activating Modules Tys-I, Tys-2, and the Valine-activating Module Srf-2

We constructed hybrids between modules with different amino acid specificities to further localize the sites of substrate recognition. The codons for selected conserved sequence motifs were used as fusion sites between the two coding regions. The corresponding codons of the two modules were compared, and suitable restriction sites were introduced into the motifs II, III, IV, V, and VI at identical sites by mutation with PCR (Table I). In all but one case, the mutations remain silent. In motif VI, one variable amino acid position was changed from aspartic acid in the Srf-2 protein and alanine in the Tys-1 protein to glycine in the hybrid protein (Table I). With this strategy, no alterations were introduced into the sequence and the length of the variable regions between the core motifs of the two modules. Various hybrid genes were constructed from the coding regions of tys-1, tys-2, and srf-2 (Fig. 1). The combined reading frames were cloned into the expression vector pMalc2 and transferred into the E. coli strain XL1-Blue, and hybrid proteins were expressed as fusions with the maltose-binding protein. In all cases, the expressed proteins were soluble in E. coli. The overexpressed protein was estimated to account for about 20% of total cell protein (Fig. 2) after 3 h of induction. The proteins were purified, and the amino acid adenylating activity was tested after affinity chromatography and anion exchange chromatography, when appropriate. The purity of the proteins was estimated by PAGE analysis (Fig. 2).

Table I.

Introduction of restriction sites into conserved sequence motifs


Motif II Motif III Motif IV Motif V Motif VI

Consensusa  <UNL>LK</UNL>AGXAYVPID YTSGT<UNL>TG</UNL>XPKG NX<UNL>YG</UNL>PGE G<UNL>EL</UNL>CIGG L<UNL>P</UNL>XYMVP
Srf-2  <UNL>LK</UNL>AGAAYVPLD YTSGS<UNL>TG</UNL>KPKG N<UNL>GYG</UNL>KPKG G<UNL>EL</UNL>CVGG L<UNL>PD</UNL>YMVP
Tys-1  <UNL>LK</UNL>AGGAYVPID YTSGT<UNL>TG</UNL>KPKG N<UNL>AYG</UNL>PTE G<UNL>EL</UNL>CIGG L<UNL>PA</UNL>YMLP
Hybridb  <UNL>LK</UNL>      <UNL>TG</UNL>   <UNL>AYG</UNL>   <UNL>EL</UNL>   <UNL>PG</UNL>
Restriction sitec CTT  AAG ACC  GGT CAT  ATG CAG  CTC CCC  GGG
Enzyme BfrI AgeI NdeI SacI SmaI

a  Relevant amino acid sequence of selected core regions in one-letter code, the codons of the underlined residues are affected by the introduction of a restriction site. X, variable position.
b  Relevant amino acid sequence after introduction of the restriction site.
c  The restriction sites were introduced into the condons of the underlined amino acids by PCR.

Only hybrid proteins constructed in motif V showed detectable activity in the ATP/PPi exchange reaction (Table II). The proteins TS-III, TS-IV, TS-VI, and ST-II were fused at the motifs III, IV, VI, and II, respectively. We were unable to detect any adenylate forming activity with phenylalanine or valine with these proteins after purification by affinity chromatography on dextrin (Table II). The proteins TS-V.1 and ST-V were fused at corresponding positions within motif V (Fig. 1). In construct TS-V.1, the sequences N-terminal to the fusion site were derived from the phenylalanine-activating module Tys-1, and vice versa in construct ST-V the N-terminal part originates from the valine-activating module Srf-2. Protein TS-V.1 activates only phenylalanine and for protein ST-V, only activation of valine and isoleucine were determined (Table II). The ratio of isoleucine adenylation in relation to that of valine was about 18% and thus comparable to the results obtained with protein Srf-2. The amino acid specificity of the two modules is therefore determined by regions N-terminal to the motif V.

Nucleotide Specificity of Amino Acid Adenylate-forming Hybrid Proteins

The truncated proteins Tys-1 and Srf-2 were tested for their acceptance of the ATP analogues 2'-deoxyadenosine triphosphate (dATP), ATPgamma S, and AMP-PNP in the amino acid adenylation reaction with their cognate amino acids as substrates. When ATP was replaced by dATP, we found with the module Tys-1 a reduction in the adenylation of phenylalanine to a value of about 42% (Table III). The valine-activating module Srf-2 accepted dATP at a higher ratio of about 79% relative to ATP. With the nucleotide analogue ATPgamma S, the relative activity of module Tys-1 was 66% in contrast to about 45% with module Srf-2. The analogue AMP-PNP was not accepted by the two modules. It was obviously not bound by module Tys-1, as no effects on the activity were detected when AMP-PNP was provided in combination with ATP (Table III). However, the activity of module Srf-2 was reduced to about 80%, indicating a competition with ATP. These results demonstrate that in addition to their amino acid substrate specificities, the two peptide synthetase modules are also different in their acceptance of ATP analogues.

Table III.

Nucleotide specificity of hybrid modules

Standard assay conditions were used with valine and phenylalanine as substrates. Values are given in percent activity in relation to amino acid activation with ATP. ND, not determined.
Module dATP ATPgamma S AMP-PNP AMP-PNP + ATP

Tys-1 46  ± 5 66  ± 5 0 100
TS-V.1 60  ± 9 62  ± 6 ND ND
Srf-2 79  ± 10 45  ± 7 0.5 80
ST-V 82  ± 10 29  ± 6 ND ND

The two hybrid modules TS-V.1 and ST-V were also tested for their nucleotide specificities. With phenylalanine as amino acid substrate, module TS-V.1 showed with dATP an activity of 60% and with ATPgamma S an activity of 62% in the adenylation reaction when compared to ATP. For the analogue ATPgamma S, the result resembles closely the specificities of the module Tys-1. The acceptance for dATP was enhanced but the nucleotide was still accepted at a lower extent when compared to the module Srf-2. On the other hand, the values obtained with module ST-V were similar to the values obtained with module Srf-2. Module ST-V adenylates valine with dATP at about 82% and with ATPgamma S at about 29% when compared to the adenylation with ATP (Table III). Our results indicate that in addition to the amino acid specificity, the regions responsible for the discrimination between ATP, dATP and ATPgamma S are also located in the N-terminal end of the two peptide synthetase modules.

Catalytic Efficiency and Substrate Affinity of the Hybrid Modules

We compared the specific activities of the hybrid modules TS-V.1, TS-V.2, and ST.V with the activities of the corresponding modules Srf-2, Tys-1, and Tys-2, respectively. The activity of module ST-V was reduced to about 0.5% when compared with Srf-2 and with valine and ATP as substrates (Table II). In contrast, the hybrid module TS-V.1 had a 4-fold higher activity than module Tys-1. This indicates that residues C-terminal to motif V contribute considerably to the catalytic effectiveness of amino acid adenylating modules and might be involved in the modulation of the velocity of the enzymatic reaction. The truncation of 31 amino acid residues from the N-terminal end of module TS-V.1 had a strong impact on the specific activity of the resulting module TS-V.2. The activity was reduced to about 0.5%, and the module TS-V.2 was even less active than the module Tys-2 with the identical N-terminal deletion. This effect might indicate cooperative interactions between the N terminus of the Tys region and the C terminus of the Srf region in the hybrid module TS-V.1, which could explain the observed high activity. The relative low specific activity of the hybrid module ST-V might therefore be contributed to the failure of the large N-terminal extension of the Srf region to interact with the C-terminal Tys region.

The binding affinities for the cognate amino acid substrates and for ATP were further analyzed. We determined the kinetic constants (Km(apparent)) from Lineweaver-Burk plots in dependence on the concentration of both reaction partners. Concentrations were between 0.05 mM and 0.5 mM for ATP and between 0.1 mM and 1 mM for the amino acid substrate. The tested modules showed only minor variations in the substrate binding affinities. Modules ST-V and Srf-2 had similar Km(apparent) values for valine of about 1.25 and 1.7 mM. Additionally, the binding affinities for ATP were similar with 0.8 mM for module ST-V and 0.4 mM for module Srf-2. The substrate binding activities for the two modules Tys-1 and TS-V.1 were also in comparable ranges. The Km(apparent) values for phenylalanine were 0.5 mM for module TS-V.1 and 0.3 mM for module Tys-1. The affinities for ATP were also similar and were estimated at 0.8 mM for module TS-V.1 and at 1 mM for module Tys-1. The results indicated that substrate binding in the constructed hybrids might be similar compared to the modules Srf-2 and Tys-1. Thus, the observed differences in the specific activities of the two hybrid modules do obviously not result from major alterations in the substrate binding affinities.


DISCUSSION

We constructed hybrid modules from amino acid adenylating modules with different substrate specificities and derived from different peptide synthetases. Highly homologous regions within the modules were used as specific sites for the construction of gene fusions by in vitro recombination. We have shown that this approach might be useful in the localization and analysis of active sites in isolated modules of multifunctional enzymes. The phenylalanine adenylating activity was previously confined by C-terminal deletions to the first 535 amino acid residues of the wild type 1077 residue subunit (27). This truncated module corresponds to our construct Tys-1. A further C-terminal deletion of 53 residues including motif VI results in the completely inactive module Tys-3. These findings agree with previous reports where residues located within this deletion have been identified to possibly interact with the adenosine moiety of ATP (22) and might therefore be essential for the adenylating reaction.

The N-terminal deletion of 31 amino acid residues in construct Tys-2 results in a reduction of the specific activity to about 11%. However, the deletion does not affect the substrate specificity, and the substrate binding sites of tyrocidine synthetase I should therefore be located between the amino acid positions 32 and 535. This size of 504 amino acid residues might also come close to the limits by which the amino acid adenylating activity of tyrocidine synthetase I could be confined by terminal deletions. We were able to further confine the sites responsible for substrate specificity only by the construction of hybrid modules. The modules Srf-2 and Tys-1 carried corresponding truncations at the C-terminal ends including the motif VII. The deletion did not affect the amino acid adenylating activity as previously reported for tyrocidine synthetase I (27) and gramicidin S synthetase I (28). When aligned to Tys-1, module Srf-2 shows an N-terminal extension of about 600 amino acid residues with the conserved motif I (8). The extension might be involved in the elongation of the growing surfactin peptide, but detailed knowledge about its significance and function is not yet available. Our construct Srf-3 carries a truncation of this extension to a position corresponding to the N terminus of module Tys-2 and lacks any valine adenylating activity. However, fusions at corresponding sites from five different modules to the N terminus of the seventh module of surfactin synthetase were shown to retain their specificities and resulted in proteins with amino acid adenylating activity (29). Residues further N-terminal to that position seem therefore not to affect the substrate discrimination. We assume that the inability to fold into a functional conformation caused the inactivity of our construct Srf-3 rather than the deletion of residues involved in substrate binding.

By analyzing hybrid modules, we could confine the regions responsible for discrimination the amino acid substrates in both modules N-terminal to motif V. For tyrocidine synthetase I, the amino acid specificity is determined by residues within the amino acid positions 32 and 362. However, the involvement of residues C-terminal to motif V in the recognition of common substrate moieties like the carbonyl or amino groups cannot be excluded. The formation of binding pockets seems to be unaffected since the binding affinities for the cognate amino acid substrates are only slightly modified in the hybrid modules ST-V and TS-V.1.

The acceptance of the ATP analogues dATP and ATPgamma S was also determined from regions N-terminal to motif V, indicating that the recognition of the ribosyl and the phosphate moieties of ATP might also occur in these parts of the enzymes. Most of the conserved sequence motifs in peptide synthetases seem to be involved in ATP binding and cleavage (8). The sequence of motif III occurs in all peptide synthetase modules and related carbonic acid-activating enzymes (8, 22). It is analogous to glycine-rich P-loops described for other nucleotide-binding proteins (36-39). Substitution of the conserved lysine residue with threonine by site-directed mutagenesis of motif III in tyrocidine synthetase I results in the loss of amino acid adenylating activity (20). The lysine is supposed to be involved in the binding of phosphate moieties from ATP. This agrees with our findings where the selectivity for the sulfur-substituted gamma -phosphate group is determined by a region containing motif III. The involvement of further residues located C-terminal in the binding of nucleotides was shown by photoaffinity labeling and site-specific mutagenesis (20-23). Three regions C-terminal to motif V spanning amino acid positions Gly373-Trp383, Leu483-Lys494, and Trp405-Arg416 respectively to the N-terminal end of the module Tys-1 could be labeled with 2-azidoadenosine triphosphate. The first region is close to motif V and starts only 6 residues further C-terminal. The labeling with the ATP analogue may indicate the involvement of these regions in the recognition and binding of adenosine. The binding of the ribosyl moiety should be in close vicinity. We found that discrimination of the 2'-hydroxyl residue was determined by regions N-terminal to motif V, indicating that distantly located residues may coordinate in the three-dimensional structure of the enzymes to form the nucleotide binding site.

Despite similar affinities for substrate binding, the catalytic efficiency of the hybrid modules was considerably altered. We observed a dramatic reduction in the specific activity with module ST-V and a considerable enhancement with module TS-V.1. These differences might be explained by modifications in the three-dimensional structure of our constructs. The positioning of the two substrates relative to each other could be altered, resulting in an enhanced or retarded catalysis. Modifications in the substrate binding affinities of the hybrid modules do not seem to be responsible for the modulation of the catalytic efficiency.

Peptide synthetases are members of a superfamily of adenylate-forming enzymes. The common reaction of all members is the ATP-dependent activation of carboxy group substrates as acyladenylates (6). The conserved sequence motifs described for modules of peptide synthetases are also present in other members of this superfamily (17, 18, 40-42). The recently solved structure of firefly luciferase represents the first three-dimensional model of a member of the adenylate-forming superfamily (43). Luciferase is folded in a large N-terminal domain of about 440 residues and a small C-terminal domain of about 100 residues. The two domains are separated by a wide cleft, the proposed active site of the enzyme. A potential substrate binding site may be located between sequences corresponding to the motifs II and IV of peptide synthetases. Sequences homologous to motif V are located close to the hinge of the two domains within the large N-terminal domain in luciferase. The structure agrees with our results where peptide synthetase modules can be divided at motif V into a large N-terminal domain determining the amino acid specificity and part of the nucleotide binding site and into a smaller C-terminal domain with about 170 residues involved in adenosine binding and substrate positioning. We were unable to construct amino acid adenylating hybrids with the motifs II, III, IV, and VI as fusion sites. They may therefore be located within the two domains of the enzymes, and the construction of hybrids could have affected the functionally active conformation of these regions. The fungal peptide synthetases responsible for the biosynthesis of cyclosporin and enniatin are reported to modify certain amino acid substrates by methylation (11, 16). In these cases, the corresponding modules carry an insertion of about 430 amino acid residues with homologies to N-methyltransferases. The insertion was always found to be located between motifs V and VI (11, 16). This further supports our view that parts of the region between these two motifs may serve as spacer between the two postulated domains and even large inserts seem to be compatible with a functionally active conformation of the enzyme.


FOOTNOTES

*   This work was supported by a grant of the Commission of Scientific Support of the Freie Universität Berlin and by EU Grant PL 950176. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
   To whom correspondence should be addressed. Tel.: 49-30-838-3463; Fax: 49-30-838-6702; E-mail: fbern{at}chemie.fu-berlin.de.
1    The abbreviations used are: PCR, polymerase chain reaction; ATPgamma S, adenosine 5'-O-(3-thiotriphosphate); AMP-PNP, adenylyl imidodiphosphate; PAGE, polyacrylamide gel electrophoresis; MES, 2-(N-morpholino)ethanesulfonic acid.

Acknowledgments

We thank Yon Oek Lee for providing plasmid pGC12 and are grateful to Cornelia Bartsch and Clemens Kieker for technical assistance.


REFERENCES

  1. Cosmina, P., Rodriguez, F., de Ferra, F., Grandi, G., Perego, M., Venema, G., and van Sinderen, D. (1993) Mol. Microbiol. 8, 821-831 [Medline] [Order article via Infotrieve]
  2. Marahiel, M. A., Krause, M., and Skarpeid, H. J. (1985) Mol. Gen. Genet. 201, 231-236 [Medline] [Order article via Infotrieve]
  3. Menkhaus, M., Ullrich, C., Kluge, B., Vater, J., Vollenbroich, D., and Kamp, R. M (1993) J. Biol. Chem. 268, 7678-7684 [Abstract/Free Full Text]
  4. Mittenhuber, G., Weckermann, R., and Marahiel, M. A. (1989) J. Bacteriol. 171, 4881-4887 [Medline] [Order article via Infotrieve]
  5. Lipmann, F. (1980) Adv. Microbiol. Physiol. 21, 227-266 [Medline] [Order article via Infotrieve]
  6. Weckermann, R., Fürba, R., and Marahiel, M. A. (1988) Nucleic Acids Res. 16, 11841 [Medline] [Order article via Infotrieve]
  7. Kleinkauf, H., and von Döhren, H. (1990) Eur. J. Biochem. 192, 1-15 [Abstract]
  8. Marahiel, M. A. (1992) FEBS Lett. 307, 40-43 [CrossRef][Medline] [Order article via Infotrieve]
  9. Stachelhaus, T., and Marahiel, M. A. (1995) FEMS Microbiol. Lett. 125, 3-14 [CrossRef][Medline] [Order article via Infotrieve]
  10. Bernhard, F., Demel, G., Soltani, K., von Döhren, H., and Blinov, V. (1996) DNA Sequence 6, 315-330
  11. Haese, A., Schubert, M., Herrmann, M., and Zocher, R. (1993) Mol. Microbiol. 7, 905-914 [Medline] [Order article via Infotrieve]
  12. Krause, M., Marahiel, M. A., von Döhren, H., and Kleinkauf, H. (1985) J. Bacteriol. 162, 1120-1125 [Medline] [Order article via Infotrieve]
  13. Scott-Craig, J. S., Panaccione, D. G., Pocard, J.-A., and Walton, J. D. (1992) J. Biol. Chem. 267, 26044-26049 [Abstract/Free Full Text]
  14. Turgay, K., Krause, M., and Marahiel, M. A. (1992) Mol. Microbiol. 6, 529-546 [Medline] [Order article via Infotrieve]
  15. van Sinderen, D., Galli, G., Cosmina, P., de Ferra, F., Withoff, S., Venema, G., and Grandi, G. (1993) Mol. Microbiol. 8, 833-841 [Medline] [Order article via Infotrieve]
  16. Weber, G., Schörgendorfer, K., Schneider-Scherzer, E., and Leitner, E. (1994) Curr. Genet. 26, 120-125 [Medline] [Order article via Infotrieve]
  17. Babbitt, P. C., Kenyon, G. L., Martin, B. M., Charest, H., Sylvestre, M., Scholten, J. D., Chang, K. H., Liang, P. H., and Dunaway-Mariano, D. (1992) Biochemistry 31, 5594-5604 [Medline] [Order article via Infotrieve]
  18. MacCabe, A. P., van Liempt, H., Palissa, H., Unkles, S. E., Riach, M. B. R., Pfeifer, E., von Döhren, H., and Kinghorn, J. R. (1991) J. Biol. Chem. 266, 12646-12654 [Abstract/Free Full Text]
  19. van Liempt, H., Pfeifer, E., Schwecke, T., Palissa, H., and von Döhren, H. (1991) Biomed. Biochim. Acta 50, 256-259
  20. Gocht, M., and Marahiel, M. A. (1994) J. Bacteriol. 176, 2654-2662 [Abstract]
  21. Pavela-Vrancic, M., Pfeifer, E., van Liempt, H., Schäfer, H.-J., von Döhren, H., and Kleinkauf, H. (1994) Biochemistry 33, 6276-6283 [Medline] [Order article via Infotrieve]
  22. Pavela-Vrancic, M., Pfeifer, E., Schröder, W., von Döhren, H., and Kleinkauf, H. (1994) J. Biol. Chem. 269, 14962-14966 [Abstract/Free Full Text]
  23. Tokita, K., Hori, K., Kurotsu, T., Kanda, M., and Saito, T. (1993) J. Biochem. (Tokyo) 114, 522-527 [Abstract]
  24. Schlumbohm, W., Stein, T., Ullrich, C., Vater, J., Krause, M., Marahiel, M. A., Kruft, V., and Wittmann-Liebold, B. (1991) J. Biol. Chem. 266, 23135-23141 [Abstract/Free Full Text]
  25. Vollenbroich, D., Kluge, B., D'Souza, C., Zuber, P., and Vater, J. (1993) FEBS Lett. 325, 220-224 [CrossRef][Medline] [Order article via Infotrieve]
  26. Vollenbroich, D., Mehta, N., Zuber, P., Vater, J., and Kamp, R. M. (1994) J. Bacteriol. 176, 395-400 [Abstract]
  27. Dieckmann, R., Lee, Y. O., van Liempt, H., von Döhren, H., and Kleinkauf, H. (1995) FEBS Lett. 357, 212-216 [CrossRef][Medline] [Order article via Infotrieve]
  28. Stachelhaus, T., and Marahiel, M. A. (1995) J. Biol. Chem. 270, 6163-6169 [Abstract/Free Full Text]
  29. Stachelhaus, T., Schneider, A., and Marahiel, M. A. (1995) Science 269, 69-72 [Medline] [Order article via Infotrieve]
  30. Hamoen, L. W., Eshuis, H., Jongbloed, J., Venema, G., and van Sinderen, D. (1995) Mol. Microbiol. 15, 55-63 [Medline] [Order article via Infotrieve]
  31. Bullock, W. O., Fernandez, J. M., and Short, J. M. (1987) BioTechniques 5, 376-381
  32. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  33. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254 [CrossRef][Medline] [Order article via Infotrieve]
  34. Laemmli, U. K. (1970) Nature 227, 680-685 [Medline] [Order article via Infotrieve]
  35. Ullrich, C., Kluge, B., Palacz, Z., and Vater, J. (1991) Biochemistry 30, 6503-6508 [Medline] [Order article via Infotrieve]
  36. Fry, D. C., Kuby, S. A., and Mildvan, A. S. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 907-911 [Abstract]
  37. Pai, E. F., Kabsch, W., Krengek, U., Holmes, K. C., John, J., and Wittinghofer, A. (1989) Nature 341, 209-214 [CrossRef][Medline] [Order article via Infotrieve]
  38. Saraste, M., Sibbald, P. R., and Wittinghofer, A. (1990) Trends Biochem. Sci. 15, 430-434 [CrossRef][Medline] [Order article via Infotrieve]
  39. Walker, J. E., Seraste, M., Runswick, M. J., and Gay, N. J. (1982) EMBO J. 1, 945-951 [Medline] [Order article via Infotrieve]
  40. Eggen, R. I. L., Geerling, A. V. C. M., Boshoven, A. B. P., and deVos, W. M. (1991) J. Bacteriol. 173, 6383-6389 [Medline] [Order article via Infotrieve]
  41. Fulda, M., Heinz, E., and Wolter, F. P. (1994) Mol. Gen. Genet. 242, 241-249 [Medline] [Order article via Infotrieve]
  42. Pavela-Vrancic, M., van Liempt, H., Pfeifer, E., Freist, W., and von Döhren, H. (1994) Eur. J. Biochem. 220, 535-542 [Abstract]
  43. Conti, E., Franks, N. P., and Brick, P. (1996) Structure 4, 287-298 [Medline] [Order article via Infotrieve]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.